Literature DB >> 17873592

Intensive care management of patients with subarachnoid haemorrhage.

Martin Smith1.   

Abstract

PURPOSE OF REVIEW: The aim of this article is to summarize recent concepts regarding the intensive care management of patients with subarachnoid haemorrhage, emphasizing the detection and treatment of cerebral vasospasm and the management of systemic complications. RECENT
FINDINGS: Aneurysmal subarachnoid haemorrhage is a potentially devastating disease that requires complex treatment strategies and extended monitoring. The prognosis of subarachnoid haemorrhage depends on the severity of the initial bleed, the success of the procedure to secure the aneurysm and the occurrence and severity of sequelae, including cerebral vasospasm. Patients with subarachnoid haemorrhage benefit from multidisciplinary neurointensive care where management is targeted at securing the ruptured aneurysm, optimizing cardiovascular variables, detecting and treating cerebral vasospasm and managing systemic complications.
SUMMARY: The complex treatment strategies applied after subarachnoid haemorrhage call for interdisciplinary collaboration between neurosurgeons, neuroradiologists, neurointensivists and specialist nurses. Specialized neuromonitoring and neuroimaging techniques must also be available. The neurointensive care unit serves as the focal point for these combined efforts.

Entities:  

Mesh:

Year:  2007        PMID: 17873592     DOI: 10.1097/ACO.0b013e3282efa686

Source DB:  PubMed          Journal:  Curr Opin Anaesthesiol        ISSN: 0952-7907            Impact factor:   2.706


  7 in total

Review 1.  A Review of the Effectiveness of Neuroimaging Modalities for the Detection of Traumatic Brain Injury.

Authors:  Franck Amyot; David B Arciniegas; Michael P Brazaitis; Kenneth C Curley; Ramon Diaz-Arrastia; Amir Gandjbakhche; Peter Herscovitch; Sidney R Hinds; Geoffrey T Manley; Anthony Pacifico; Alexander Razumovsky; Jason Riley; Wanda Salzer; Robert Shih; James G Smirniotopoulos; Derek Stocker
Journal:  J Neurotrauma       Date:  2015-09-30       Impact factor: 5.269

2.  Outcome in poor grade subarachnoid hemorrhage patients treated with acute endovascular coiling of aneurysms and aggressive intensive care.

Authors:  Christopher J Taylor; Fergus Robertson; David Brealey; Frankie O'shea; Tina Stephen; Stefan Brew; Joan P Grieve; Martin Smith; Ian Appleby
Journal:  Neurocrit Care       Date:  2011-06       Impact factor: 3.210

3.  Elevated cardiac troponin I and functional recovery and disability in patients after aneurysmal subarachnoid hemorrhage.

Authors:  Joyce K Miketic; Marilyn Hravnak; Susan M Sereika; Elizabeth A Crago
Journal:  Am J Crit Care       Date:  2010-01-27       Impact factor: 2.228

4.  Red blood cell transfusion and mortality effect in aneurysmal subarachnoid hemorrhage: a systematic review and meta-analysis protocol.

Authors:  Shane W English; Michaël Chassé; Alexis F Turgeon; Alan Tinmouth; Amélie Boutin; Giuseppe Pagliarello; Dean Fergusson; Lauralyn McIntyre
Journal:  Syst Rev       Date:  2015-04-03

5.  Clinical outcomes of treatment for intracranial aneurysm in elderly patients.

Authors:  Jun Hee Park; Young Im Kim; Yong Cheol Lim
Journal:  J Cerebrovasc Endovasc Neurosurg       Date:  2014-09-30

6.  Effects of energy drinks on blood pressure, heart rate, and electrocardiographic parameters: An experimental study on healthy young adults.

Authors:  Shokoufeh Hajsadeghi; Fatemeh Mohammadpour; Mohammad Javad Manteghi; Kiarash Kordshakeri; Masoud Tokazebani; Elham Rahmani; Morteza Hassanzadeh
Journal:  Anatol J Cardiol       Date:  2015-03-23       Impact factor: 1.596

Review 7.  Transcranial Doppler Ultrasound: Physical Principles and Principal Applications in Neurocritical Care Unit.

Authors:  Antonello D'Andrea; Marianna Conte; Raffaella Scarafile; Lucia Riegler; Rosangela Cocchia; Enrica Pezzullo; Massimo Cavallaro; Andreina Carbone; Francesco Natale; Maria Giovanna Russo; Giovanni Gregorio; Raffaele Calabrò
Journal:  J Cardiovasc Echogr       Date:  2016 Apr-Jun
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.